Board Meeting5 Aug 2026, 03:55 pm
Biogen Pharmachem declares unaudited Q2 FY27 results
AI Summary
Biogen Pharmachem Industries Ltd announced that its Board of Directors, in a meeting held on August 5, 2026, considered and approved the unaudited financial results for the quarter ended June 30, 2026. The meeting commenced at 3:15 PM and concluded at 3:35 PM. The financial results have been reviewed by the Audit Committee and approved by the Board. The Statutory Auditors have carried out a limited review. The company operates in a single segment. Previous periods' figures have been re-grouped or re-arranged where necessary.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results for the quarter ended June 30, 2026, were declared.
- Audit Committee reviewed and Board approved the results.
- Statutory Auditors performed a limited review.
- Company has a single business segment.
Price Impact
More from BIOGEN